NASDAQ:BLCM - Bellicum Pharmaceuticals SEC Filings & 10K Form

$1.17
-0.02 (-1.68 %)
(As of 09/16/2019 10:03 AM ET)
Today's Range
$1.16
Now: $1.17
$1.2497
50-Day Range
$0.9460
MA: $1.20
$1.52
52-Week Range
$0.78
Now: $1.17
$6.64
Volume97,215 shs
Average Volume1.18 million shs
Market Capitalization$54.11 million
P/E RatioN/A
Dividend YieldN/A
Beta1.53

SEC Filings

Bellicum Pharmaceuticals (NASDAQ:BLCM) SEC Filings

DateFilerForm TypeView
09/11/2019
6:01 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
2:36 PM
Bellicum Pharmaceuticals (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
08/30/2019
3:01 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
4:20 PM
ARMISTICE CAPITAL, LLC (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13G
08/26/2019
4:02 PM
Bellicum Pharmaceuticals (Subject)
Boxer Capital, LLC (Filed by)
Form SC 13G
08/23/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
Naeve Gregory S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
3:03 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
3:09 PM
BAKER BROS. ADVISORS LP (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13D
08/19/2019
4:27 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:25 PM
Bellicum Pharmaceuticals (Filer)
Form 424B5
08/16/2019
5:15 AM
Bellicum Pharmaceuticals (Subject)
Form FWP
08/16/2019
5:12 AM
Bellicum Pharmaceuticals (Filer)
Form 424B5
08/15/2019
4:28 PM
Bellicum Pharmaceuticals (Subject)
Form FWP
08/05/2019
3:05 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
8:13 AM
Bellicum Pharmaceuticals (Filer)
Form CT ORDER
07/30/2019
11:15 PM
Bellicum Pharmaceuticals (Filer)
Form EFFECT
07/29/2019
7:15 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
3:57 PM
Bellicum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/23/2019
3:51 PM
Bellicum Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/10/2019
3:25 PM
Bellicum Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
06/24/2019
3:17 PM
Bellicum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/19/2019
3:21 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:05 PM
Bellicum Pharmaceuticals (Issuer)
Klimovsky Judith V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Bellicum Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Bellicum Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
BROWN JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
Huber Reid M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:03 PM
Bellicum Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:58 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:58 PM
Bellicum Pharmaceuticals (Issuer)
Woodard Jr Joseph Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:58 PM
Bellicum Pharmaceuticals (Issuer)
Williams Rosemary Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:58 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:57 PM
Bellicum Pharmaceuticals (Issuer)
Naeve Gregory S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:57 PM
Bellicum Pharmaceuticals (Issuer)
Smith Alan K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:57 PM
Bellicum Pharmaceuticals (Issuer)
Foster Aaron E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
8:06 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
8:02 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
3:05 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:06 PM
Bellicum Pharmaceuticals (Filer)
Form DEFA14A
05/07/2019
3:32 PM
Bellicum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:24 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
2:43 PM
Bellicum Pharmaceuticals (Filer)
Form DEF 14A
04/12/2019
4:16 PM
Bellicum Pharmaceuticals (Filer)
Form CT ORDER
04/10/2019
3:10 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2019
8:01 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
3:25 PM
Bellicum Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
3:05 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2019
3:01 PM
Bellicum Pharmaceuticals (Issuer)
Foster Aaron E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/19/2019
9:11 AM
Bellicum Pharmaceuticals (Filer)
Form CT ORDER
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2019
3:02 PM
Bellicum Pharmaceuticals (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
3:12 PM
Bellicum Pharmaceuticals (Issuer)
Naeve Gregory S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
3:11 PM
Bellicum Pharmaceuticals (Issuer)
Smith Alan K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
3:10 PM
Bellicum Pharmaceuticals (Issuer)
Spencer David M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
3:10 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
3:09 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
9:09 AM
Bellicum Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/18/2019
10:45 AM
Bellicum Pharmaceuticals (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
01/04/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
Williams Rosemary Y. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2018
8:23 PM
Bellicum Pharmaceuticals (Issuer)
Klimovsky Judith V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
8:16 PM
Bellicum Pharmaceuticals (Issuer)
Klimovsky Judith V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2018
8:14 PM
Bellicum Pharmaceuticals (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
8:09 PM
Bellicum Pharmaceuticals (Issuer)
Mokari Atabak (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2018
3:05 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2018
4:12 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:17 PM
Bellicum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2018
9:03 AM
Bellicum Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
10/05/2018
4:11 PM
Bellicum Pharmaceuticals (Filer)
Form 424B5
10/05/2018
3:39 PM
Bellicum Pharmaceuticals (Filer)
Form 424B5
10/05/2018
3:37 PM
Bellicum Pharmaceuticals (Filer)
Form 424B5
10/05/2018
3:31 PM
Bellicum Pharmaceuticals (Filer)
Form 424B5
10/05/2018
3:26 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
3:02 PM
Bellicum Pharmaceuticals (Issuer)
Spencer David M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
11:15 PM
Bellicum Pharmaceuticals (Filer)
Form EFFECT
08/23/2018
3:03 PM
Bellicum Pharmaceuticals (Issuer)
Naeve Gregory S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
3:51 PM
Bellicum Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/26/2018
1:44 PM
Bellicum Pharmaceuticals (Filer)
Form CT ORDER
07/20/2018
3:01 PM
Bellicum Pharmaceuticals (Issuer)
Spencer David M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2018
3:06 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2018
3:03 PM
Bellicum Pharmaceuticals (Issuer)
Musso Alan A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2018
3:03 PM
Bellicum Pharmaceuticals (Issuer)
Spencer David M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2018
3:03 PM
Bellicum Pharmaceuticals (Issuer)
Naeve Gregory S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2018
3:02 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2018
3:02 PM
Bellicum Pharmaceuticals (Issuer)
Smith Alan K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:33 PM
Bellicum Pharmaceuticals (Issuer)
McGuyer Frank B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:33 PM
Bellicum Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:32 PM
Bellicum Pharmaceuticals (Issuer)
BROWN JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:32 PM
Bellicum Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:31 PM
Bellicum Pharmaceuticals (Issuer)
Huber Reid M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:31 PM
Bellicum Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:30 PM
Bellicum Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:31 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
3:40 PM
Bellicum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/29/2018
8:29 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
8:26 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2018
3:49 PM
Bellicum Pharmaceuticals (Issuer)
Musso Alan A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
3:10 PM
BAKER BROS. ADVISORS LP (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13G/A
05/08/2018
3:46 PM
Bellicum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
3:41 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Management Fee

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel